DRIVEN: Accelerating Medical Entrepreneurship in the Northeast
Award amount
$3,167,970Program and phase
STTR · Phase IIAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CELDARA MEDICAL, LLC
- Proposal award date
- 2019-09-01
- Contract end date
- 2021-08-31
- UEI
- MMVKQXZUBMQ7
- Solicitation number
- GM18-001
- Topic code
- 500
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development of CM-HZ01 as a non-alpha-IL2 therapeutic for the treatment of metastatic melanoma
- Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
- Development of CM-IAV1 for Treatment of High-risk Pandemic Influenzas
- Anti-hIAPP for the preservation of pancreatic function in Type 2 Diabetes
- Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- MusiQuest STEAM: interactive digital media for K-5 STEM education integrating audio and music
- A generative-AI-assisted platform for rapidly creating interactive,accurate 3D explainers for all of biomedical science and medicine (TABA Supplement)
- Introducing Young Children to Biomedical Science with a Screenless Interactive Device (infinibook)
- Flu Finders: Data Literacy through Wastewater Monitoring
- The STEMfluidics Platform: Inspiring STEM Learning and Career Exploration with Microfluidics
Research funding history
52 SBIR/STTR records share this UEI (2009–2025). Reported award amounts total $49,304,220. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services